Nonacus
Tracked across 1 events · 6 articles · First seen Sep 02, 2026 · Last active Sep 04, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
A study published in European Urology Oncology, led by the University of Birmingham and diagnostics company Nonacus, found that the GALEAS Bladder urine test detected 92% of bladder cancers in a real-world NHS trial involving…
Impact: Commercialized the GALEAS Bladder test and is the primary beneficiary. The study validates its product, potentially increasing sales and market share in bladder cancer diagnostics.
Sep 02, 2026 · 6 articles
80
Nonacus deployed test United Kingdom — National Health ServiceUrine test detects 92%...
50
Bupa reimbursed test NonacusUrine test detects 92%...
50
The London Clinic reimbursed test NonacusUrine test detects 92%...
ERGEN INTELLIGENCE
Track Nonacus live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard